FDA Inspection 1273078 — DB Biologics, LLC

DB Biologics, LLC — FEI 3006761306

The FDA completed an inspection of DB Biologics, LLC on June 18, 2025 in Harrisburg, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Harrisburg, PA (United States)

Citations

IDCFRDescription
33321 CFR 640.64(e)Prevention of contamination